Search - tctmd.com

Displaying 181 - 200 of 1167

Sort: Relevancy | Date

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

Soft Robotics Approach Brings Hemodynamics to 3D Aortic Models

News Daily News

Soft Robotics Approach Brings Hemodynamics to 3D Aortic Models

Yael L. Maxwell

March 03, 2023

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

News Conference News STS 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

Yael L. Maxwell

February 02, 2023

Post-TAVI Stroke More Often Noted at Specialized Centers

News Daily News

Post-TAVI Stroke More Often Noted at Specialized Centers

January 31, 2023

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

January 20, 2023

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

News Daily News

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

December 29, 2022

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 28, 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

December 22, 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

December 07, 2022

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

News Conference News PCR London Valves 2022

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

November 30, 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

News Conference News PCR London Valves 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

November 29, 2022

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

News Daily News

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

November 29, 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

November 28, 2022

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

News Daily News

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

November 24, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

October 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.